Lisa E.S. Crose

876 citations
13 papers · 687 indexed · h-index 13
Topics
Sarcoma Diagnosis and Treatment (6 papers)Hippo pathway signaling and YAP/TAZ (6 papers)Cancer-related gene regulation (4 papers)
Partner nations
United States

In The Last Decade

Lisa E.S. Crose

13 papers receiving 684 citations

Peers

Lisa E.S. Crose
Comparison fields: 5 of 71
  • Molecular Biology 425
  • Pulmonary and Respiratory Medicine 234
  • Cell Biology 194
  • Oncology 141
  • Cancer Research 112
Replace Lanping Quan with:
Lanping Quan China
Galina Semenova United States
David Herrero‐Martín Spain
Clare F. Malone United States
Paola Magnaghi Italy
Oriol Arqués Spain
D A E Parolin Canada
Annalisa Chiriatti Italy
Abdelkader Selmi France
Lisa E.S. Crose relative to Lanping Quan China Lanping Quan's profile →
Citations per field
00.5×3.2×
Lanping Quan · 1×
Citations per year

Countries citing papers authored by Lisa E.S. Crose

Since Specialization
Citations

This map shows the geographic impact of Lisa E.S. Crose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E.S. Crose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E.S. Crose more than expected).

Fields of papers citing papers by Lisa E.S. Crose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa E.S. Crose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E.S. Crose. The network helps show where Lisa E.S. Crose may publish in the future.

Co-authorship network of co-authors of Lisa E.S. Crose

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa E.S. Crose. A scholar is included among the top collaborators of Lisa E.S. Crose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa E.S. Crose. Lisa E.S. Crose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 17
2 15
3 51
4 49
5 20
6 44
7 59
8 138
9 98
10 57
11 36
12 32
13 71

About Lisa E.S. Crose

Lisa E.S. Crose is a scholar working on Cell Biology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 13 papers that have together received 687 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Cell Biology (194 citations), Cancer Research (112 citations) and Pulmonary and Respiratory Medicine (234 citations). Lisa E.S. Crose has collaborated with scholars based in United States. Frequent co-authors include Corinne M. Linardic, Brian Belyea, Rex C. Bentley, Frederic G. Barr, Noah Sciaky, Gary L. Johnson, Thomas L. Hilder, Stephen Safe, Jing Li and Erik Hedrick. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026